Paediatric trials for Covaxin underway
India has commenced paediatric trials for Covaxin, its indigenously-manufactured vaccine against COVID-19. Covaxin, manufactured by Hyderabad-based firm Bharat Biotech, is one of four vaccines authorised for use in India alongside Covishield (produced by the Serum Institute of India on license from AstraZeneca), the Russian-manufactured Sputnik-V, and the Moderna vaccine. Bharat Biotech announced last month that …
